Literature DB >> 8869841

Antibiotic usage: policy, clinical and pharmacoeconomic outcomes.

C Carbon1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8869841     DOI： 10.2165/00003495-199600522-00015

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  2 in total

Review 1.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

2.  Cost-effectiveness opportunities for new antibiotics.

Authors:  A Hillman
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981
  2 in total
  2 in total

Review 1.  Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.

Authors:  M Young; G L Plosker
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Application of the ATC/DDD methodology to monitor antibiotic drug use.

Authors:  S Natsch; Y A Hekster; R de Jong; E R Heerdink; R M Herings; J W van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.